VAKSEA
VakSea is a biotechnology company that makes immune-boosting protein to immunize and protect shrimp from the disease. VakSea is driven by its mission is to increase the efficiency and quality of aquaculture production. By increasing the aquaculture industry’s disease resilience. The company has developed and insect larvae platform to bio-manufacture functional feed additives that protect fish and shrimp from viral diseases.
VAKSEA
Industry:
Animal Feed Aquaculture Biotechnology Farming
Founded:
2016-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.vaksea.com
Total Employee:
1+
Status:
Active
Contact:
980-253-2357
Email Addresses:
[email protected]
Total Funding:
40 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF WordPress Wordpress Plugins AJAX Libraries API PHP PHP 7 OVH
Similar Organizations
Avant Meats
Avant Meats is a technology company with patent-pending solutions to produce animal meat and protein without the animal
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Dimension Therapeutics
Dimension Therapeutics is a gene therapy company developing novel treatments for rare diseases.
Future Fields
Future Fields develops cellular growth media that enables customers to create lab-grown meat at a lower cost.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Rx Green Technologies
Rx Green Technologies delivers and supports research-backed products to commercial cannabis cultivators.
Sound Agriculture
Sound Agriculture uses molecular discovery to create climate resilient crops, enhancing harvest yields for growers.
Spotlight Therapeutics
Spotlight Therapeutics is a biotechnology company that develops biologics targeted to specific cell populations in gene editing.
Current Advisors List
Current Employees Featured
Founder
Investors List
Iowa AgriTech Accelerator
Iowa AgriTech Accelerator investment in Pre Seed Round - VakSea
More informations about "VakSea"
VakSea - Crunchbase Company Profile & Funding
VakSea is a biotechnology company that makes immune-boosting protein to immunize and protect shrimp from the disease. VakSea is driven by its mission is to increase the efficiency …See details»
Global Aquaculture Innovation Award finalist: VakSea
Sep 4, 2018 · VakSea’s oral vaccine is grown in low-cost and efficient cabbage looper (Trichoplusia ni) larvae, which are then ground up and manufactured with other ingredients into a pelleted aquafeed that can be administered to fish …See details»
VakSea Company Profile 2024: Valuation, Funding & Investors
Description. Producer of immune-boosting proteins intended to increase the efficiency and quality of aquaculture production.See details»
Pellet-based oral vaccine holds promise for VNN …
Jan 2, 2018 · VakSea selected the insect species because of its low cost and efficient system. “Insects are food for fish, so this will make the pellet palatable to the fish,” he said. The two-part manufacturing process consists of farming the …See details»
VakSea - Products, Competitors, Financials, Employees, …
VakSea focuses on sustainable aquaculture solutions, operating within the biotechnology and aquaculture industries. The company specializes in producing immune-boosting proteins using …See details»
VakSea | Baltimore, MD, USA Startup - gust.com
VakSea uses insect larvae to make immunoprotective feed additives that protect farmed fish and shrimp from disease outbreaks. Find investment information and connect with VakSea, a …See details»
VakSea - Funding, Financials, Valuation & Investors - Crunchbase
VakSea is a biotechnology company that makes immune-boosting protein to immunize and protect shrimp from the disease.See details»
You Decide: Global Aquaculture Innovation Award ... - Global …
VakSea. Mihir is CEO of VakSea, a U.S.-based start-up that has developed an innovative system that uses insect larvae to affordably produce specialty, immune-boosting proteins that can be …See details»
VakSea - Crunchbase
VakSea is a biotechnology company that makes immune-boosting protein to immunize and protect shrimp from the disease.See details»
Startup’s first product a potential game changer
Jan 3, 2018 · The startup’s proprietary vaccine technology was developed at the University of Maryland Baltimore County (UMBC) in the lab of Dr Vik Vakharia beginning in 2014. VakSea filed a provisional patent application in 2016.See details»
UMBC scientist's oral vaccine to save fish industry millions
Aug 30, 2016 · He succeeded in the lab, and, along with BioHealth Innovation, formed a company called VakSea, Inc. to convert the lab success into a commercial product. Recently, VakSea …See details»
UMBC scientist launches company to commercialize new oral
Sep 26, 2016 · Recently, VakSea licensed the technology from UMBC and will collaborate with Allotropic Tech, Inc. a bwtech@UMBC company that will produce the vaccine product. It will …See details»
Start-Up Spotlight: VakSea - Successful Farming
Jul 2, 2018 · VakSea, a start-up based in Maryland, is using university level technology to provide a better way of vaccinating aquaculture.See details»
oral vaccine - Responsible Seafood Advocate
An orally administered vaccine product holds great promise for aquaculture, and Maryland-based startup VakSea is on the cusp of providing one. Sensing a major opportunity, the company’s …See details»
UMBC Scientist Launches Company To Commercialize New Oral …
Aug 11, 2016 · Vakharia is continuing to work on new ways to increase the vaccine’s efficacy, and VakSea submitted a Small Business Innovation Research (SBIR) grant to the National …See details»
VakSea - Contacts, Employees, Board Members, Advisors
VakSea is a biotechnology company that makes immune-boosting protein to immunize and protect shrimp from the disease.See details»
Functional feed firm wins $50,000 award | The Fish Site
Nov 5, 2019 · VakSea, which bio-manufactures functional feed additives for fish and shrimp, has won the won the AquaSG ‘19 conference Aquaculture Innovation Challenge. VakSea uses …See details»
VakSea - Responsible Seafood Advocate
An orally administered vaccine product holds great promise for aquaculture, and Maryland-based startup VakSea is on the cusp of providing one. Sensing a major opportunity, the company’s …See details»
Article: Pellet-based oral vaccine holds promise for VNN protection
Jan 4, 2018 · An oral vaccine delivered via fish feed that protects European sea bass as tiny as 1 gram from Viral Nervous Necrosis (VNN) could be ready for market in the next 12 to 18 …See details»
Potential application of plant-produced vaccines in aquaculture
Oct 11, 2021 · An orally administered vaccine product holds great promise for aquaculture, and Maryland-based startup VakSea is on the cusp of providing one. Sensing a major opportunity, …See details»